ARTES Biotechnology entered in development of SARS-CoV-2 vaccine Kumar Jeetendra | April 27, 2020 ARTES Biotechnology, the German-based biotech organization gaining practical experience in process improvement for recombinant immunizations, entered advancement of SARS-CoV-2 antibody applicants dependent on its infection like molecule (VLP) based stage advances METAVAX® and SplitCore. METAVAX® is the organization’s foundation for the improvement of immunizations based on wrapped infection like molecule nanostructures (eVLPs) in light of …
WHO finishing hydroxychloroquine preliminary for COVID-19 Kumar Jeetendra | July 5, 2020 The World Health Organization says that it is ending an effort to if anti-malaria medication hydroxychloroquine helps patients hospitalised with COVID-19. WHO said on July 4 that it has”accepted that the recommendation” from the committee overseeing the trial to stop testing of hydroxychloroquine and lopinavir/ritonavir, a medication combination used in the treatment of HIV/AIDS. The …
Lab-made infection mirrors COVID-19 infection: Research Kumar Jeetendra | July 24, 2020 Airborne and potentially deadly, the virus which causes COVID-19 can only be studied safely under high level biosafety conditions. Scientists handling the virus that is infectious must wear full-body biohazard matches with pressurized respirators, and operate inside labs with multiple containment degrees and technical ventilation systems. While necessary to protect laboratory employees, these security precautions …
Import licenses for rapid diagnostic units of 3 firms dropped, 15 suspended by DCGI Kumar Jeetendra | July 25, 2020 India’s drug regulator has cancelled the rapid diagnostic kit import licences of 3 firms and suspended that of 15 other people saying the USFDA has eliminated the producers in their listing of coronavirus serology test kits using directions that they shouldn’t be dispersed. The three firms are Cadila Healthcare, MDAAC International and N W Overseas …
BioNTech, Fosun Pharmaceutical dispatch another COVID-19 vaccine trial Kumar Jeetendra | August 5, 2020 Germany’s BioNTech and China’s Shanghai Fosun Pharmaceutical on Wednesday declared the start of another COVID-19 vaccine trial in China with a total of 144 participants. “The study is designed to support the regulatory approval process for the Chinese market and plans to confirm the safety and immunogenicity profile observed in participants in the German and …
High-quality SARS-CoV-2 Antigen Protein Kits Kumar Jeetendra | January 5, 2021 AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development. These new kit products include SARS-CoV-2 inhibitor screening kits, antibody titer serologic assay kits, antigen detection kit and antigen pre-coated plates. SARS-CoV-2 is an enveloped positive-stranded RNA virus that consists of …
New class of drugs effective against SARS-COV-2 and many RNA viruses Kumar Jeetendra | July 4, 2024 Researchers may have discovered a new class of front-line drugs that can both prevent the spread of new viruses and limit their severity. In laboratory tests, the already available treatments showed promise in fighting a range of existing RNA viruses, including SARS-Cov-2 and other human coronaviruses. Scientists have identified a new class of drugs with …
